Temocapril (also known as temocaprilum [Latin]; brand name Acecol) is an ACE inhibitor. It was not approved for use in the US.
It is administered as inactive prodrug, then converted to its active metabolite, temocaprilat.
It was patented in 1984 and approved for medical use in 1994.